載入...
New substituted quinoxalines inhibit triple-negative breast cancer by specifically downregulating the c-MYC transcription
Conventional chemotherapy remains the primary treatment option for triple-negative breast cancer (TNBC). However, the current chemotherapeutic drugs have limited effects on TNBC, and often lead to serious side effects as well as drug resistance. Thus, more effective therapeutic options are sorely ne...
Na minha lista:
| 發表在: | Nucleic Acids Res |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Oxford University Press
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6846596/ https://ncbi.nlm.nih.gov/pubmed/31584090 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/nar/gkz835 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|